What is the Weight Loss Drug Mounjaro?

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro (tirzepatide) is a prescription injectable medication that activates two hormone pathways in your brain and gut to reduce hunger and support sustainable weight loss. In FDA clinical trials, participants taking the highest dose lost an average of 22.5% of their starting body weight over 68 weeks—significantly more than older GLP-1 only medications.

How Mounjaro Works for Weight Loss

Mounjaro activates two separate receptor pathways: GLP-1 and GIP. The GLP-1 receptor slows stomach emptying and increases feelings of fullness after eating. The GIP receptor works on a separate brain center that controls appetite and glucose metabolism. Together, these dual actions create a more powerful signal that tells your body you've had enough food and reduces cravings between meals.

Unlike older single-action GLP-1 medications, tirzepatide's dual mechanism produces greater weight loss and more stable blood sugar control. Most patients notice reduced appetite within the first few doses, though peak appetite suppression typically develops over 4 to 8 weeks as the dose gradually increases.

Clinical Trial Results and Weight Loss Outcomes

The SURMOUNT clinical trial program tested tirzepatide in over 4,500 participants across multiple studies. Patients receiving the 15 mg maintenance dose lost an average of 22.5% of their body weight, while those on the 10 mg dose lost approximately 19.5%. These results were measured over 68 weeks and compared to a placebo group, which lost only 2.4% on average.

Weight loss continued beyond the initial months for most participants, with many reaching their lowest weight between 6 and 12 months of treatment. The SURMOUNT-4 trial specifically examined tirzepatide in patients with established cardiovascular disease, showing consistent weight loss benefits and improved cardiometabolic markers including blood pressure and cholesterol levels.

Tirzepatide vs. Semaglutide: Key Differences

Both tirzepatide and semaglutide are GLP-1 receptor agonists, but tirzepatide adds a second mechanism by also activating GIP receptors. This dual action typically produces greater weight loss than semaglutide alone. In head-to-head analyses, patients on tirzepatide lost approximately 2 to 3 pounds more per month on average compared to those on semaglutide at similar treatment stages.

Semaglutide has a longer track record in the weight loss market and may be preferred by some patients who tolerate single-mechanism therapy well. Tirzepatide is the newer option and offers stronger appetite suppression for patients seeking maximum weight loss results. PlexusDx offers both compounded semaglutide and tirzepatide, allowing you to choose the medication that aligns with your goals and health history.

Common Side Effects and Safety Profile

Gastrointestinal side effects are the most frequently reported with tirzepatide and include nausea, vomiting, diarrhea, and constipation. These effects are typically mild to moderate, occur during the dose-escalation phase, and decrease significantly as your body adjusts over 2 to 3 weeks. Most patients experience minimal to no side effects once they reach their maintenance dose.

Serious side effects are uncommon but can include pancreatitis, gallbladder problems, and severe dehydration. Tirzepatide is not recommended for patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. Your healthcare provider will review your complete medical history before prescribing to ensure tirzepatide is appropriate and safe for you.

PlexusDx Compounded Tirzepatide Injections

PlexusDx offers compounded tirzepatide injections prepared by licensed 503A compounding pharmacies at $289 per month to start. This flat pricing means your dose may need to go up as your treatment progresses, but your monthly price won't. PlexusDx serves all 50 states with no insurance requirement, no membership fees, and HSA/FSA eligibility.

When you start tirzepatide through PlexusDx, your dose begins low and increases gradually over weeks to minimize side effects and allow your body to adapt. You'll receive guidance on injection technique, storage, and when to adjust your dose based on your hunger levels and weight loss progress. Optional add-on genetic testing through the Precision Peptide Genetic Test ($99 after your first month) can reveal how your unique genetic variants in GLP1R, GIPR, and other appetite-pathway genes may influence your response to tirzepatide.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Mounjaro the same as tirzepatide?

Mounjaro is the brand name for tirzepatide manufactured by Eli Lilly. PlexusDx offers compounded tirzepatide from licensed 503A pharmacies, which contains the same active ingredient at a more accessible price point at $289/mo month-to-month, or from $249/mo on the 6-month plan.

How much weight can I expect to lose on tirzepatide?

Clinical trial data shows an average weight loss of 19.5% to 22.5% of starting body weight over 68 weeks, depending on dose. Individual results vary based on diet, exercise, metabolism, and genetic factors. PlexusDx's optional Precision Peptide Genetic Test can reveal genetic variants affecting your appetite pathways and potential response.

How quickly do I see weight loss results on tirzepatide?

Most patients notice reduced appetite within the first 1 to 2 doses, but measurable weight loss typically appears after 2 to 4 weeks. The dose escalates gradually over several months, and maximum weight loss effects usually develop between months 3 and 6 of treatment.

Can I afford tirzepatide without insurance?

Yes. PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan with no insurance required and no membership fee. Treatment is HSA and FSA eligible, and pricing remains flat regardless of dose—your dose may go up, but your price won't.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 pathways and 150+ genetic insights, including variants in GLP1R (rs6923761) and GIPR (rs1800437) that influence how your body responds to tirzepatide and other GLP-1/GIP medications.

What's the difference between compounded tirzepatide and brand-name Mounjaro?

Both contain the same active ingredient and work identically in your body. Compounded tirzepatide from licensed 503A pharmacies costs significantly less (at $289/mo month-to-month, or from $249/mo on the 6-month plan with PlexusDx) while maintaining the same pharmaceutical standards and effectiveness. Compounded medications are not FDA-approved but are regulated and prepared under strict pharmacy guidelines.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Lilly Weight Loss Drug
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.